| 6.1 - 7.8 | 3.9 - 11.1 | P | logistics |
n | 193 | 510 |
|
|
Age, median [Q1, Q3] | 51.00 [40.00, 65.00] | 54.00 [43.00, 65.00] | 0.255 | / |
Male, n | 114 | 307 | 0.796 | / |
Male, (%) | 59.07% | 60.20% | ||
ethnicity |
|
|
|
|
white, n | 126 | 312 |
|
|
white, (%) | 65.28% | 61.18% |
|
|
BLACK/AFRICAN AMERICAN, n | 21 | 59 |
|
|
BLACK/AFRICAN AMERICAN, (%) | 10.88% | 11.57% |
|
|
AMERICAN INDIAN/ALASKA NATIVE, n | 0 | 2 |
|
|
AMERICAN INDIAN/ALASKA NATIVE, (%) | 0.00% | 0.39% |
|
|
PORTUGUESE, n | 2 | 4 |
|
|
PORTUGUESE, (%) | 1.04% | 0.78% |
|
|
UNKNOWN, n | 24 | 63 |
|
|
UNKNOWN, (%) | 12.44% | 12.35% |
|
|
ASIAN, n | 5 | 14 |
|
|
ASIAN, (%) | 2.59% | 2.75% |
|
|
OTHER, n | 7 | 21 |
|
|
OTHER, (%) | 3.63% | 4.12% |
|
|
HISPANIC/LATINO, n | 5 | 21 |
|
|
HISPANIC/LATINO, (%) | 2.59% | 4.12% |
|
|
UNABLE TO OBTAIN, n | 3 | 14 |
|
|
UNABLE TO OBTAIN, (%) | 1.55% | 2.75% |
|
|
Aps III, median [Q1, Q3] | 56.00 [40.00, 79.00] | 59.00 [41.00, 84.00] | 0.307 | / |
inSOFA, median [Q1, Q3] | 1.00 [0, 3.00] | 1.00 [0, 4.00] | 0.410 | / |
▲SOFA, median [Q1, Q3] | 1.00 [−1.00, 3.00] | 1.00 [−1.00, 3.00] | 0.769 | / |
Glu_meana (mmol/L), median [Q1, Q3] | 6.90 [6.55, 7.38] | 7.55 [6.42, 8.61] | <0.001* | / |
Glu_cvb, median [Q1, Q3] | 0.21 [0.16, 0.25] | 0.22 [0.16, 0.31] | 0.003 | 0.137 |
Glu_frequency* (n/day), median [Q1, Q3] | 3.97 [2.58, 4.78] | 4.43 [3.24, 6.10] | <0.001* | 0.142 |
LOS in ICUc, median [Q1, Q3] | 4.99 [3.09, 12.61] | 4.95 [2.96, 11.67] | 0.579 | / |
LOS in hospitald, median [Q1, Q3] | 16.85 [10.62, 27.52] | 16.62 [9.03, 26.71] | 0.265 | / |
antibiotic day, median [Q1, Q3] | 1.00 [0, 3.00] | 1.00 [0, 3.00] | 0.582 | / |
die, n | 94 | 241 | 0.736 | / |
die, (%) | 48.70% | 47.25% | ||
blood-infection, n | 59 | 142 | 0.513 | / |
blood-infection, (%) | 30.57% | 27.84% | ||
Abdominal-infection, n | 24 | 71 | 0.711 | / |
Abdominal-infection, (%) | 12.44% | 13.92% | ||
urinary-infection, n | 20 | 57 | 0.892 | / |
urinary-infection, (%) | 10.36% | 11.18% | ||
respiratory-infection, n | 38 | 78 | 0.172 | / |
respiratory-infection, (%) | 19.69% | 15.29% | ||
diabetes, n | 25 | 148 | <0.001* | 0.002 |
diabetes, (%) | 12.95% | 29.02% |
|
|
hypoglycemia, n | 3 | 11 | 0.768 | / |
hypoglycemia, (%) | 2.63% | 3.58% | ||
die, n | 16 | 68 | 0.069 | 0.275 |
die, (%) | 8.29% | 13.33% | ||
hyperlipidemia, n | 29 | 96 | 0.2697 | / |
hyperlipidemia, (%) | 25.44% | 31.27% |